Is a Positive RSV Test Enough? Assessing the Clinical Value of Multiplex PCR, Viral Load and Host-Response Biomarkers in Children

Background: A positive respiratory syncytial virus (RSV) test establishes viral detection but does not necessarily explain disease severity, identify clinically relevant coinfections, or predict disease progression. Multiplex molecular testing, viral load assessment, and host-response biomarkers may provide additional information, yet their ability to improve clinical assessment and decision-making in children with RSV infection remains uncertain. Aim: This narrative review examines the clinical value of advanced diagnostic tools in pediatric RSV infection, addressing both antimicrobial stewardship through reducing unnecessary antibiotic use and acute clinical decision-making through pathogen identification and severity stratification, with a focus on multiplex polymerase chain reaction (PCR), viral load assessment, and inflammatory biomarkers. Results: Multiplex PCR broadens etiological characterization by detecting additional respiratory pathogens, but viral co-detection is not consistently associated with greater disease severity, while bacterial detection must be distinguished from colonization and clinically significant coinfection. Cycle threshold (Ct) values are assay-dependent proxies for the amount of target viral RNA rather than standardized quantitative viral-load measurements and have been associated with disease severity and respiratory support requirements in some pediatric cohorts. However, inter-assay variability, sampling time, and prolonged RNA shedding limit their reliability as independent prognostic indicators. Host-response biomarkers address a different diagnostic dimension. Procalcitonin (PCT) may be more informative for invasive bacterial infection than for localized bacterial coinfection, whereas C-reactive protein (CRP) lacks sufficient specificity. Leukocyte-derived indices, including neutrophil-to-lymphocyte (NLR) and monocyte-to-lymphocyte (MLR) ratios, have been associated with severity in selected RSV cohorts, but their incremental prognostic utility remains unvalidated. Across these approaches, greater analytical sensitivity or more extensive biological information does not necessarily translate into greater clinical utility. Conclusions: The central challenge in pediatric RSV diagnostics is not simply detecting additional pathogens or measuring more biological parameters, but determining which findings meaningfully contribute to patient assessment, risk stratification, and antibiotic decision-making. Current evidence does not support the isolated use of molecular co-detection, Ct values, or inflammatory biomarkers to establish bacterial coinfection or predict disease severity. Integrated diagnostic strategies combining pathogen detection, viral burden, host-response markers, and clinical findings may improve clinical decision-making, support appropriate antibiotic use, and reduce unnecessary antibiotic prescriptions. Future studies should evaluate their impact on patient management and antimicrobial stewardship.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-18
DOI
https://doi.org/10.3390/jcm15229045
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Is a Positive RSV Test Enough? Assessing the Clinical Value of Multiplex PCR, Viral Load and Host-Response Biomarkers in Children

Alecsandra Munteanu, Elena-Lia Spoială, Eliza Cloțea, Vasile Valeriu Lupu et al.
1 links
Journal of Clinical Medicine
Respiratory viral infections research
article

Is a Positive RSV Test Enough? Assessing the Clinical Value of Multiplex PCR, Viral Load and Host-Response Biomarkers in Children

Alecsandra Munteanu, Elena-Lia Spoială, Eliza Cloțea, Vasile Valeriu Lupu, Paolo Manzoni, Otilia Elena Frăsinariu, Cătălina Luncă, Leonard Iosif Pertea, Magdalena D. Cuciureanu, Oana Falup‐Pecurariu, Cristina Gavrilovici, Anastasia Chirvasa, Ionuț Daniel Iancu
article en

Abstract

Background: A positive respiratory syncytial virus (RSV) test establishes viral detection but does not necessarily explain disease severity, identify clinically relevant coinfections, or predict disease progression. Multiplex molecular testing, viral load assessment, and host-response biomarkers may provide additional information, yet their ability to improve clinical assessment and decision-making in children with RSV infection remains uncertain. Aim: This narrative review examines the clinical value of advanced diagnostic tools in pediatric RSV infection, addressing both antimicrobial stewardship through reducing unnecessary antibiotic use and acute clinical decision-making through pathogen identification and severity stratification, with a focus on multiplex polymerase chain reaction (PCR), viral load assessment, and inflammatory biomarkers. Results: Multiplex PCR broadens etiological characterization by detecting additional respiratory pathogens, but viral co-detection is not consistently associated with greater disease severity, while bacterial detection must be distinguished from colonization and clinically significant coinfection. Cycle threshold (Ct) values are assay-dependent proxies for the amount of target viral RNA rather than standardized quantitative viral-load measurements and have been associated with disease severity and respiratory support requirements in some pediatric cohorts. However, inter-assay variability, sampling time, and prolonged RNA shedding limit their reliability as independent prognostic indicators. Host-response biomarkers address a different diagnostic dimension. Procalcitonin (PCT) may be more informative for invasive bacterial infection than for localized bacterial coinfection, whereas C-reactive protein (CRP) lacks sufficient specificity. Leukocyte-derived indices, including neutrophil-to-lymphocyte (NLR) and monocyte-to-lymphocyte (MLR) ratios, have been associated with severity in selected RSV cohorts, but their incremental prognostic utility remains unvalidated. Across these approaches, greater analytical sensitivity or more extensive biological information does not necessarily translate into greater clinical utility. Conclusions: The central challenge in pediatric RSV diagnostics is not simply detecting additional pathogens or measuring more biological parameters, but determining which findings meaningfully contribute to patient assessment, risk stratification, and antibiotic decision-making. Current evidence does not support the isolated use of molecular co-detection, Ct values, or inflammatory biomarkers to establish bacterial coinfection or predict disease severity. Integrated diagnostic strategies combining pathogen detection, viral burden, host-response markers, and clinical findings may improve clinical decision-making, support appropriate antibiotic use, and reduce unnecessary antibiotic prescriptions. Future studies should evaluate their impact on patient management and antimicrobial stewardship.

Journal of Clinical MedicineVol. 15(22)
Carol Davila University of Medicine and Pharmacy (RO), Clinical Emergency Hospital Bucharest (RO), Grigore T. Popa University of Medicine and Pharmacy (RO), Transylvania University of Brașov (RO), Ospedale degli Infermi (IT), Istituto Nazionale di Fisica Nucleare, Sezione di Torino (IT), Torino e-district (IT), Ospedale degli Infermi (IT), University of Turin (IT)
Good health and well-being
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon